Cargando…

Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain

PURPOSE: [(11)C]Lu AE92686 is a positron emission tomography (PET) radioligand that has recently been validated for examining phosphodiesterase 10A (PDE10A) in the human striatum. [(11)C]Lu AE92686 has high affinity for PDE10A (IC (50) = 0.39 nM) and may also be suitable for examination of the subst...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kai-Chun, Stepanov, Vladimir, Amini, Nahid, Martinsson, Stefan, Takano, Akihiro, Nielsen, Jacob, Bundgaard, Christoffer, Bang-Andersen, Benny, Grimwood, Sarah, Halldin, Christer, Farde, Lars, Finnema, Sjoerd J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215309/
https://www.ncbi.nlm.nih.gov/pubmed/27817159
http://dx.doi.org/10.1007/s00259-016-3544-9
_version_ 1782491744620773376
author Yang, Kai-Chun
Stepanov, Vladimir
Amini, Nahid
Martinsson, Stefan
Takano, Akihiro
Nielsen, Jacob
Bundgaard, Christoffer
Bang-Andersen, Benny
Grimwood, Sarah
Halldin, Christer
Farde, Lars
Finnema, Sjoerd J.
author_facet Yang, Kai-Chun
Stepanov, Vladimir
Amini, Nahid
Martinsson, Stefan
Takano, Akihiro
Nielsen, Jacob
Bundgaard, Christoffer
Bang-Andersen, Benny
Grimwood, Sarah
Halldin, Christer
Farde, Lars
Finnema, Sjoerd J.
author_sort Yang, Kai-Chun
collection PubMed
description PURPOSE: [(11)C]Lu AE92686 is a positron emission tomography (PET) radioligand that has recently been validated for examining phosphodiesterase 10A (PDE10A) in the human striatum. [(11)C]Lu AE92686 has high affinity for PDE10A (IC (50) = 0.39 nM) and may also be suitable for examination of the substantia nigra, a region with low density of PDE10A. Here, we report characterization of regional [(11)C]Lu AE92686 binding to PDE10A in the nonhuman primate (NHP) brain. METHODS: A total of 11 PET measurements, seven baseline and four following pretreatment with unlabeled Lu AE92686 or the structurally unrelated PDE10A inhibitor MP-10, were performed in five NHPs using a high resolution research tomograph (HRRT). [(11)C]Lu AE92686 binding was quantified using a radiometabolite-corrected arterial input function and compartmental and graphical modeling approaches. RESULTS: Regional time-activity curves were best described with the two-tissue compartment model (2TCM). However, the distribution volume (V (T)) values for all regions were obtained by the Logan plot analysis, as reliable cerebellar V (T) values could not be derived by the 2TCM. For cerebellum, a proposed reference region, V (T) values increased by ∼30 % with increasing PET measurement duration from 63 to 123 min, while V (T) values in target regions remained stable. Both pretreatment drugs significantly decreased [(11)C]Lu AE92686 binding in target regions, while no significant effect on cerebellum was observed. Binding potential (BP (ND)) values, derived with the simplified reference tissue model (SRTM), were 13–17 in putamen and 3–5 in substantia nigra and correlated well to values from the Logan plot analysis. CONCLUSIONS: The method proposed for quantification of [(11)C]Lu AE92686 binding in applied studies in NHP is based on 63 min PET data and SRTM with cerebellum as a reference region. The study supports that [(11)C]Lu AE92686 can be used for PET examinations of PDE10A binding also in substantia nigra. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00259-016-3544-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5215309
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-52153092017-01-24 Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain Yang, Kai-Chun Stepanov, Vladimir Amini, Nahid Martinsson, Stefan Takano, Akihiro Nielsen, Jacob Bundgaard, Christoffer Bang-Andersen, Benny Grimwood, Sarah Halldin, Christer Farde, Lars Finnema, Sjoerd J. Eur J Nucl Med Mol Imaging Original Article PURPOSE: [(11)C]Lu AE92686 is a positron emission tomography (PET) radioligand that has recently been validated for examining phosphodiesterase 10A (PDE10A) in the human striatum. [(11)C]Lu AE92686 has high affinity for PDE10A (IC (50) = 0.39 nM) and may also be suitable for examination of the substantia nigra, a region with low density of PDE10A. Here, we report characterization of regional [(11)C]Lu AE92686 binding to PDE10A in the nonhuman primate (NHP) brain. METHODS: A total of 11 PET measurements, seven baseline and four following pretreatment with unlabeled Lu AE92686 or the structurally unrelated PDE10A inhibitor MP-10, were performed in five NHPs using a high resolution research tomograph (HRRT). [(11)C]Lu AE92686 binding was quantified using a radiometabolite-corrected arterial input function and compartmental and graphical modeling approaches. RESULTS: Regional time-activity curves were best described with the two-tissue compartment model (2TCM). However, the distribution volume (V (T)) values for all regions were obtained by the Logan plot analysis, as reliable cerebellar V (T) values could not be derived by the 2TCM. For cerebellum, a proposed reference region, V (T) values increased by ∼30 % with increasing PET measurement duration from 63 to 123 min, while V (T) values in target regions remained stable. Both pretreatment drugs significantly decreased [(11)C]Lu AE92686 binding in target regions, while no significant effect on cerebellum was observed. Binding potential (BP (ND)) values, derived with the simplified reference tissue model (SRTM), were 13–17 in putamen and 3–5 in substantia nigra and correlated well to values from the Logan plot analysis. CONCLUSIONS: The method proposed for quantification of [(11)C]Lu AE92686 binding in applied studies in NHP is based on 63 min PET data and SRTM with cerebellum as a reference region. The study supports that [(11)C]Lu AE92686 can be used for PET examinations of PDE10A binding also in substantia nigra. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00259-016-3544-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-11-05 2017 /pmc/articles/PMC5215309/ /pubmed/27817159 http://dx.doi.org/10.1007/s00259-016-3544-9 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Yang, Kai-Chun
Stepanov, Vladimir
Amini, Nahid
Martinsson, Stefan
Takano, Akihiro
Nielsen, Jacob
Bundgaard, Christoffer
Bang-Andersen, Benny
Grimwood, Sarah
Halldin, Christer
Farde, Lars
Finnema, Sjoerd J.
Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
title Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
title_full Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
title_fullStr Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
title_full_unstemmed Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
title_short Characterization of [(11)C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
title_sort characterization of [(11)c]lu ae92686 as a pet radioligand for phosphodiesterase 10a in the nonhuman primate brain
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215309/
https://www.ncbi.nlm.nih.gov/pubmed/27817159
http://dx.doi.org/10.1007/s00259-016-3544-9
work_keys_str_mv AT yangkaichun characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT stepanovvladimir characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT amininahid characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT martinssonstefan characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT takanoakihiro characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT nielsenjacob characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT bundgaardchristoffer characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT bangandersenbenny characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT grimwoodsarah characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT halldinchrister characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT fardelars characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain
AT finnemasjoerdj characterizationof11cluae92686asapetradioligandforphosphodiesterase10ainthenonhumanprimatebrain